I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
imt-2021-0013 - Supplementary Material - Ruxolitinib, a JAK..:
Figshare Future Science Group (6457551)
;
Eduardo Huarte (114248)
;
Michael Peel (3912052)
...
https://figshare.com/articles/figure/imt-2021-0013_-_Supplementary_Material_-_Ruxolitinib_a_JAK1_JAK2_selective_inhibitor_ameliorates_acute_and_chronic_steroid-refractory_GvHD_mouse_models/16586351. , 2021
Link:
https://doi.org/10.25402/fsg.16586351.v1
RT Journal T1
imt-2021-0013 - Supplementary Material - Ruxolitinib, a JAK1/JAK2 selective inhibitor, ameliorates acute and chronic steroid-refractory GvHD mouse models
UL https://suche.suub.uni-bremen.de/peid=base-ftsmithonian:oai:figshare.com:article_16586351&Exemplar=1&LAN=DE A1 Figshare Future Science Group (6457551) A1 Eduardo Huarte (114248) A1 Michael Peel (3912052) A1 Ashish Juvekar (8410443) A1 Philip Dubé (11406872) A1 Sarala Sarah (11406875) A1 Lynn Stephens (11406878) A1 Becky Stewart (11406881) A1 Brian Long (2217403) A1 Philip Czerniak (11406884) A1 Julian Oliver (11406887) A1 Paul Smith (175833) YR 2021 K1 Cancer Therapy (excl. Chemotherapy and Radiation Therapy) K1 Clinical Pharmacology and Therapeutics K1 Graft-versus-host disease K1 ruxolitinib K1 JAK K1 corticosteroid K1 stem cell transplantation K1 cytokines K1 steroid-refractory JF https://figshare.com/articles/figure/imt-2021-0013_-_Supplementary_Material_-_Ruxolitinib_a_JAK1_JAK2_selective_inhibitor_ameliorates_acute_and_chronic_steroid-refractory_GvHD_mouse_models/16586351 LK http://dx.doi.org/https://doi.org/10.25402/fsg.16586351.v1 DO https://doi.org/10.25402/fsg.16586351.v1 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)